MetaCap

Fennec Pharmaceuticals Statistics

NASDAQ: FENCHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

13.09-0.36 (-2.68%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Fennec Pharmaceuticals by the numbers

Fennec Pharmaceuticals has a market capitalization of $462.1 million based on 35.31M shares outstanding. Its trailing P/E ratio is 436.3, and its forward P/E is 12.5. The stock trades 21.3% above its 50-day average and 38.0% above its 200-day average.

Average daily trading volume is 220.87K shares, or about $2.9 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

FENC valuation vs. peer median

FENC compared with the median of 8 peer companies
MetricFENCPeer medianDifference
Market cap$462.14M$474.93M-3%
Avg. volume220.87K974.35K-77%

Peer median across 8 companies: RGNX, SANA, DNA, VALN, IRLA, PROK, ETRA, TECX.

Valuation

Market cap
$462.14M
P/E (TTM)
436.33
Price / sales (latest FY)
10.35

Price and trading

Previous close
13.45
Open
13.15
Day range
12.64 – 13.55
52-week range
5.65 – 13.85
52-week change
+66.12%
Beta
—
Volume
398.14K

Dividends and events

Annual dividend
None
Next earnings date
Nov 12, 2026

Additional statistics

Market Cap
462.14M
Pe
436.33
Forward Pe
12.47
Eps
0.03
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
13.85
Week52 Low
5.65
Avg Volume
220.87K
Shares Outstanding
35.31M
Ma50
10.79
Ma200
9.49
Earnings Date
Nov 12, 2026
Pct From52w High
-5.49%
Pct From52w Low
131.68%

Related